Squarepoint Ops LLC Aerie Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.37 - $15.23 $102,142 - $244,213	-16,035 Reduced 25.09%	47,884 $724,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $244,530 - $452,504	49,400 Added 340.24%	63,919 $479,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $367,660 - $638,842	-65,188 Reduced 81.78%	14,519 $132,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $440,378 - $836,217	62,732 Added 369.56%	79,707 $560,000
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $341,999 - $502,425	-30,212 Reduced 64.03%	16,975 $194,000
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $715,354 - $895,137	47,187 New	47,187 $755,000
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $674,591 - $1.07 Million	-51,417 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $148,291 - $235,607	16,260 Added 46.25%	51,417 $695,000
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $170,916 - $236,276	16,340 Added 86.84%	35,157 $414,000
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $21,012 - $28,243	1,751 Added 10.26%	18,817 $278,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $761,773 - $1.64 Million	-64,339 Reduced 79.04%	17,066 $230,000
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $1.5 Million - $2.12 Million	-84,466 Reduced 50.92%	81,405 $1.97 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $2.5 Million - $3.8 Million	135,716 Added 450.06%	165,871 $3.19 Million
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $1.74 Million - $2.89 Million	-59,894 Reduced 66.51%	30,155 $891,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $2.88 Million - $3.91 Million	79,372 Added 743.39%	90,049 $4.28 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $569,679 - $1.04 Million	-17,263 Reduced 61.79%	10,677 $385,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.57 Million - $2.06 Million	27,940 New	27,940 $1.72 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $502,520 - $739,865	-10,502 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $537,177 - $640,622	10,502 New	10,502 $570,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account